NPI: 1023071222 · PHILADELPHIA, PA 19153 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/10/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/10/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,638 | $2K |
| 2020 | 2,052 | $132K |
| 2021 | 6,155 | $536K |
| 2022 | 9,534 | $1.09M |
| 2023 | 11,928 | $1.47M |
| 2024 | 7,614 | $942K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 31,811 | 2,672 | $4.17M |
| 90677 | 20 | 20 | $3K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 2,685 | 168 | $2K |
| A4657 | Syringe, with or without needle, each | 2,043 | 656 | $508.94 |
| G0008 | Administration of influenza virus vaccine | 43 | 42 | $346.59 |
| 85041 | 284 | 262 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 1,924 | 476 | $0.00 |
| 83540 | 131 | 126 | $0.00 | |
| 83970 | 198 | 181 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 778 | 429 | $0.00 |
| 82108 | 117 | 112 | $0.00 | |
| 85048 | 283 | 261 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 1,505 | 138 | $0.00 |
| 82728 | 130 | 125 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 1,771 | 158 | $0.00 |
| 83550 | 131 | 126 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 67 | 45 | $0.00 |